All derivatives are protected in a manner that they can immediately implemented into synthetic peptides and will, hence, serve in topics related to Advanced Glycation Endproducts (AGEs) and related research areas like aging in general, as well as health and diseases at different ages.

References:

• Al-Abed, Y. et al.; Bioorg. Med. Chem. Lett. 1996; 6: 1577-1578.
• Oya, T. et al.; J. Biol. Chem. 1999; 274: 18492-18502
• Glomb, M.A. et al.; J. Agric. Food Chem. 2001; 49: 366-372.
• Padayatti, P.S. et al.; Invest. Ophthalmol. Vis. Sci. 2001; 42: 1299-1304.
• Gomes, R. et al.; Biochem. J. 2005; 385: 339-345.
• Sreejayan, N. et al.; Eur. J. Pharm. 2008; 593: 30-35.
• Ahmed, M.U. et al.; J. Biol. Chem. 1986; 261: 4889-4895.
• Ahmed, M.U. et al.; J. Biol. Chem. 1988; 263: 8816-8821.
• Smith, P.R. and Thornalley, P.J. Eur. J. Biochem. 1992; 210: 729-739.
• Reddy, S. et al.; Biochemistry 1995; 34: 10872-10878.
• Glomb, M.A. and Monnier, V.M.; J. Biol. Chem. 1995; 270: 10017-10026.
• Tauer, A. et al.; Eur. Food Res. Technol. 1999; 209: 72-76.
• Frolov, A. et al.; J. Peptide Sci. 2006; 12: 389.
• Stefanowicz, P. et al.; Tetrahedron Lett. 2007; 48: 967.
• Carganico, S. et al.; J. Peptide Sci. 2009; 15: 67.